BBB disruption is caused by the secretion of pro-inflammatory mediators, such as IL-1α, IL-1β, IL-6, and TNF-α, due to an increase in microglia and astrocytes in Alzheimer’s disease [35]. This evidence concerns the gene IL1B and early-onset autosomal dominant Alzheimer disease.